Zenlabs Ethica Limited (BOM:530697)
25.58
-2.42 (-8.64%)
At close: Nov 16, 2026
Zenlabs Ethica Revenue
Zenlabs Ethica had revenue of 114.36M INR in the quarter ending September 30, 2026, a decrease of -8.02%. This brings the company's total for the last twelve months to 485.60M, down -2.13% year-over-year. In the fiscal year ending March 31, 2026, Zenlabs Ethica had annual revenue of 469.23M, down -8.75%. That makes Zenlabs Ethica the 39,925th largest company in the world by revenue and 3,830th in India.
Revenue (ttm)
485.60M
Revenue Growth
-2.13%
P/S Ratio
0.34
Revenue / Employee
7.36M
Employees
66
Market Cap
166.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 469.23M | -45.00M | -8.75% |
| Mar 31, 2025 | 514.23M | -71.41M | -12.19% |
| Mar 31, 2024 | 585.63M | -83.23M | -12.44% |
| Mar 31, 2023 | 668.86M | -22.01M | -3.19% |
| Mar 31, 2022 | 690.88M | 124.48M | 21.98% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.31B |
| Chandra Bhagat Pharma | 1.17B |
| Medico Intercontinental | 864.77M |
| Medistep Healthcare | 731.36M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |
| Muller & Phipps (India) | 60.37M |